PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23768632-9 2014 Stratified by prostate-specific antigen (PSA) values, CD was higher in SPBx compared with EPBx, 47.1% versus 32.8% (OR: 2.00; 95% CI, 1.19-3.38) in patients with a PSA <4 ng/ml and 50.9% versus 42.9% in patients with a PSA from 4 ng/ml to 9.9 ng/ml (OR: 1.62; 95% CI, 1.20-2.20). Cadmium 54-56 kallikrein related peptidase 3 Homo sapiens 14-45 25227780-0 2014 DNA fragmentation, caspase 3 and prostate-specific antigen genes expression induced by arsenic, cadmium, and chromium on nontumorigenic human prostate cells. Cadmium 96-103 kallikrein related peptidase 3 Homo sapiens 33-58 25660730-0 2015 Cadmium may impair prostate function as measured by prostate specific antigen in semen: A cross-sectional study among European and Inuit men. Cadmium 0-7 kallikrein related peptidase 3 Homo sapiens 52-77 25660730-1 2015 We investigated the association between cadmium in blood and the concentration of the prostate specific antigen (PSA) in semen, including the modifying effects of zinc or the CAG polymorphism in the androgen receptor (AR). Cadmium 40-47 kallikrein related peptidase 3 Homo sapiens 86-111 23768632-9 2014 Stratified by prostate-specific antigen (PSA) values, CD was higher in SPBx compared with EPBx, 47.1% versus 32.8% (OR: 2.00; 95% CI, 1.19-3.38) in patients with a PSA <4 ng/ml and 50.9% versus 42.9% in patients with a PSA from 4 ng/ml to 9.9 ng/ml (OR: 1.62; 95% CI, 1.20-2.20). Cadmium 54-56 kallikrein related peptidase 3 Homo sapiens 41-44 23768632-9 2014 Stratified by prostate-specific antigen (PSA) values, CD was higher in SPBx compared with EPBx, 47.1% versus 32.8% (OR: 2.00; 95% CI, 1.19-3.38) in patients with a PSA <4 ng/ml and 50.9% versus 42.9% in patients with a PSA from 4 ng/ml to 9.9 ng/ml (OR: 1.62; 95% CI, 1.20-2.20). Cadmium 54-56 kallikrein related peptidase 3 Homo sapiens 164-167 18044729-0 2008 Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey. Cadmium 48-55 kallikrein related peptidase 3 Homo sapiens 0-25 21272915-0 2011 Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium. Cadmium 85-92 kallikrein related peptidase 3 Homo sapiens 39-64 21272915-0 2011 Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium. Cadmium 105-112 kallikrein related peptidase 3 Homo sapiens 39-64 21272915-1 2011 Prostate cancer associated with cadmium exposure may indicate a link between prostate specific antigen (PSA) and levels of blood cadmium (BCd) and urinary cadmium (UCd). Cadmium 32-39 kallikrein related peptidase 3 Homo sapiens 77-102 21272915-1 2011 Prostate cancer associated with cadmium exposure may indicate a link between prostate specific antigen (PSA) and levels of blood cadmium (BCd) and urinary cadmium (UCd). Cadmium 32-39 kallikrein related peptidase 3 Homo sapiens 104-107 21272915-1 2011 Prostate cancer associated with cadmium exposure may indicate a link between prostate specific antigen (PSA) and levels of blood cadmium (BCd) and urinary cadmium (UCd). Cadmium 129-136 kallikrein related peptidase 3 Homo sapiens 77-102 21272915-1 2011 Prostate cancer associated with cadmium exposure may indicate a link between prostate specific antigen (PSA) and levels of blood cadmium (BCd) and urinary cadmium (UCd). Cadmium 129-136 kallikrein related peptidase 3 Homo sapiens 104-107 21272915-1 2011 Prostate cancer associated with cadmium exposure may indicate a link between prostate specific antigen (PSA) and levels of blood cadmium (BCd) and urinary cadmium (UCd). Cadmium 129-136 kallikrein related peptidase 3 Homo sapiens 77-102 21272915-1 2011 Prostate cancer associated with cadmium exposure may indicate a link between prostate specific antigen (PSA) and levels of blood cadmium (BCd) and urinary cadmium (UCd). Cadmium 129-136 kallikrein related peptidase 3 Homo sapiens 104-107 18044729-2 2008 We evaluated total prostate-specific antigen (PSA) levels in relation to urinary cadmium concentrations and dietary zinc intake. Cadmium 81-88 kallikrein related peptidase 3 Homo sapiens 19-50 18044729-9 2008 Among men with zinc intake less than the median level of 12.67 mg/day, an increase in 1 microg/g creatinine cadmium exposure was associated with a 35% increase in PSA level. Cadmium 108-115 kallikrein related peptidase 3 Homo sapiens 163-166 33891655-8 2021 Men with an elevated PSA had statistically significantly higher levels of blood cadmium and blood lead compared to men with a normal PSA (p-values <= 0.02), with black men having higher levels. Cadmium 80-87 kallikrein related peptidase 3 Homo sapiens 21-24 34180924-0 2021 Ultrasensitive photoelectrochemical immunoassay for prostate-specific antigen based on silver nanoparticle-triggered ion-exchange reaction with ZnO/CdS nanorods. Cadmium 148-151 kallikrein related peptidase 3 Homo sapiens 52-77 16819092-6 2005 A positive association was found between blood Cd and total serum PSA. Cadmium 47-49 kallikrein related peptidase 3 Homo sapiens 66-69 16819092-11 2005 Further research is needed to ascertain whether the associations found between Cd and PSA levels are biologically important or are merely factors to be considered when interpreting PSA results clinically. Cadmium 79-81 kallikrein related peptidase 3 Homo sapiens 86-89 16819092-11 2005 Further research is needed to ascertain whether the associations found between Cd and PSA levels are biologically important or are merely factors to be considered when interpreting PSA results clinically. Cadmium 79-81 kallikrein related peptidase 3 Homo sapiens 181-184 30947036-1 2019 An all-solid-state metal-mediated Z-scheme photoelectrochemical (PEC) immunoassay was designed for sensitive detection of prostate-specific antigen (PSA) by using WO3-Au-CdS nanocomposite as photoactive material and copper ion (Cu2+) as an inhibitor. Cadmium 170-173 kallikrein related peptidase 3 Homo sapiens 122-147 33544604-6 2021 As a proof of concept, prostate-specific antigen is chosen as the target analyte to demonstrate the superiority of the Pt SAs-CdS-based PEC sensing system. Cadmium 126-129 kallikrein related peptidase 3 Homo sapiens 23-48 32025820-0 2020 Electrochemiluminescence immunoassay for the prostate-specific antigen by using a CdS/chitosan/g-C3N4 nanocomposite. Cadmium 82-85 kallikrein related peptidase 3 Homo sapiens 45-70 32025820-4 2020 In the absence of PSA, the ECL intensity signal is effectively quenches through the energy transfer and photoexcitation electron transfer between CdS/Chito/g-C3N4 emitter and quencher Fc. Cadmium 146-149 kallikrein related peptidase 3 Homo sapiens 18-21 32025820-8 2020 Graphical abstractSchematic representation of the electrochemiluminescence sensor based on a CdS/chitosan/g-C3N4 nanocomposite, which can be applied to the determination of prostate specific antigen in serum. Cadmium 93-96 kallikrein related peptidase 3 Homo sapiens 173-198 31259991-1 2019 A split-type photoelectrochemical immunosensor was designed for the ultrasensitive monitoring of prostate-specific antigen (PSA) based on a Cu2+-mediated catalytic reaction for inhibiting the in situ generation of CdS quantum dots (QDs) coupled with the enhancement of the CdS/MoS2 heterojunction; it was constructed by the stepwise modification of MoS2 QDs and CdS QDs onto an ITO electrode surface. Cadmium 214-217 kallikrein related peptidase 3 Homo sapiens 97-122 30947036-1 2019 An all-solid-state metal-mediated Z-scheme photoelectrochemical (PEC) immunoassay was designed for sensitive detection of prostate-specific antigen (PSA) by using WO3-Au-CdS nanocomposite as photoactive material and copper ion (Cu2+) as an inhibitor. Cadmium 170-173 kallikrein related peptidase 3 Homo sapiens 149-152 28033558-3 2017 Then, the sandwich complexing between the PSA, its antibodies, and the signaling nanoprobes was performed on a CdS QDs modified indium tin oxide (ITO) electrode. Cadmium 111-114 kallikrein related peptidase 3 Homo sapiens 42-45 29313657-2 2018 Herein, a universal spatial-resolved photoelectrochemical (PEC) ratiometry for biodetection of prostate-specific antigen (PSA) as model biomarker was designed for the first time based on a dual-electrode array modified by CdS@g-C3N4 heterojunction coupled with CuS quantum dots (QDs) as signal amplification tags. Cadmium 222-225 kallikrein related peptidase 3 Homo sapiens 95-126 28412658-0 2017 CdS:Mn quantum dot-functionalized g-C3N4 nanohybrids as signal-generation tags for photoelectrochemical immunoassay of prostate specific antigen coupling DNAzyme concatamer with enzymatic biocatalytic precipitation. Cadmium 0-3 kallikrein related peptidase 3 Homo sapiens 119-144 29465232-0 2018 Exciton-Plasmon Interaction between AuNPs/Graphene Nanohybrids and CdS Quantum Dots/TiO2 for Photoelectrochemical Aptasensing of Prostate-Specific Antigen. Cadmium 67-70 kallikrein related peptidase 3 Homo sapiens 129-154 29465232-4 2018 Upon addition of target PSA, the sandwiched aptamer between CdS QDs/TiO2 and AuNPs/GN reacted with the analyte analyte, thus resulting in the dissociation of AuNPs/GN from the CdS QDs/TiO2 to increase the photocurrent. Cadmium 60-63 kallikrein related peptidase 3 Homo sapiens 24-27 28340728-1 2017 A signal-switchable electrochemiluminescence (ECL) aptasensor was presented for sensitive prostate specific antigen (PSA) assay using ferrocene-graphene sheets (Fc-GNs) for high-efficiency quenching of ECL from Au nanoparticles functionalized cadmium sulfide flower-like three dimensional (3D) assemblies (Au-CdS flower-like 3D assemblies). Cadmium 309-312 kallikrein related peptidase 3 Homo sapiens 90-115 28340728-1 2017 A signal-switchable electrochemiluminescence (ECL) aptasensor was presented for sensitive prostate specific antigen (PSA) assay using ferrocene-graphene sheets (Fc-GNs) for high-efficiency quenching of ECL from Au nanoparticles functionalized cadmium sulfide flower-like three dimensional (3D) assemblies (Au-CdS flower-like 3D assemblies). Cadmium 309-312 kallikrein related peptidase 3 Homo sapiens 117-120